Results 131 to 140 of about 44,543 (288)
In this work, a novel molecular design strategy was employed to truncate large‐scale conjugated structures in covalent polymer materials. This approach significantly enhances the catalyst’s light‐harvesting capability, prolongs the lifetime of photogenerated charge carriers, and improves catalytic activity, thereby offering a new conceptual pathway for
Cui Li +4 more
wiley +1 more source
This study develops an iridium‐based nanozyme (IIN@M) with superior enzyme‐like activity and photothermal performance. It disrupts intracellular redox balance by generating reactive oxygen species and depleting glutathione, which synergistically induces ferroptosis, pyroptosis, and immunogenic cell death.
Lijun Ding +7 more
wiley +1 more source
Development of Visible-Light Driven Cu(I) Complex Photosensitizers for Photocatalytic CO2 Reduction [PDF]
Hiroyuki Takeda +4 more
openalex +1 more source
Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang +7 more
wiley +1 more source
Photodynamic therapy dosimetry: current status and the emerging challenge of immune stimulation. [PDF]
Wilson BC +3 more
europepmc +1 more source
Highly dispersed and electron‐rich Ni nanoparticles (≈2.7 nm) supported on NH2‐MIL‐125 significantly promote the dehydrogenation of hydrous hydrazine under visible‐light irradiation, achieving a turnover frequency of 220.2 h−1 at 323 K, which is more than twice that in the dark (108.1 h−1) and outperforms most reported non‐precious metal catalysts ...
Jianjun Long +6 more
wiley +1 more source
A highly effective self-supplying photosensitizer drug for the treatment of deep-tissue metastatic tumors. [PDF]
Zhang H +8 more
europepmc +1 more source
Photosensitizers in Cancer Treatment : Transaction of The 79th Annual Meeting of The JUA
Haruo Hisazumi
openalex +2 more sources
This carrier‐free, esterase‐responsive nanoaggregate integrates a mitochondria‐targeting photosensitizer with a non‐nucleotide STING agonist to achieve localized photoactivation and immune reprogramming. ICyM2 remodels tumor stroma, induces potent immunogenic cell death, and triggers intratumoral STING activation, collectively revitalizing the ...
Yixuan Zhang +18 more
wiley +1 more source

